Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia (Q74268543)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

title

Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

6

Champlin RE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

author name string

Molldrem JJ

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Wang C

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Felio K

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Kantarjian HM

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

Davis MM

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

publication date

1 September 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

page(s)

1018-1023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/79526

9 November 2019

exact match

0 references

cites work

Cytogenetic status pre-transplant as a predictor of outcome post bone marrow transplantation for chronic myelogenous leukaemia

1 reference

7 January 2021

1 reference

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

7 January 2021

Chronic myelogenous leukemia: biology and therapy

1 reference

7 January 2021

The effects of interferon-alpha on the proliferation of CML progenitor cells in vitro are not related to the precise position of the M-BCR breakpoint

1 reference

7 January 2021

Treatment with interferon-alpha preferentially reduces the capacity for amplification of granulocyte-macrophage progenitors (CFU-GM) from patients with chronic myeloid leukemia but spares normal CFU-GM.

1 reference

7 January 2021

The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism.

1 reference

7 January 2021

Identification of a graft versus host disease-associated human minor histocompatibility antigen

1 reference

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

7 January 2021

Molecular remission of chronic myeloid leukaemia following a non-myeloablative allogeneic peripheral blood stem cell transplant: in vivo and in vitro evidence for a graft-versus-leukaemia effect

1 reference

7 January 2021

Immunocytochemical and flow cytometric detection of proteinase 3 (myeloblastin) in normal and leukaemic myeloid cells

1 reference

7 January 2021

Down-regulation of a serine protease, myeloblastin, causes growth arrest and differentiation of promyelocytic leukemia cells

1 reference

7 January 2021

Phenotypic analysis of antigen-specific T lymphocytes

1 reference

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

7 January 2021

Molecular profile, tissue distribution and prognostic evaluation of a human melanoma-carcinoma antigen recognized by the murine monoclonal antibody B1.1.

1 reference

7 January 2021

Immune escape from a graft-versus-leukemia effect may play a role in the relapse of myeloid leukemias following allogeneic bone marrow transplantation

1 reference

7 January 2021

Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes

1 reference

7 January 2021

Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes

1 reference

7 January 2021

Principles for adoptive T cell therapy of human viral diseases

1 reference

7 January 2021

Endogenously synthesized peptide with an endoplasmic reticulum signal sequence sensitizes antigen processing mutant cells to class I-restricted cell-mediated lysis

1 reference

7 January 2021

Identifiers

DOI

10.1038/79526

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10973322%20AND%20SRC:MED&resulttype=core&format=json

9 November 2019

1 reference